"ZNA Middelheim is het grootste algemeen ziekenhuis van Antwerpen. Het ziekenhuis is actief in zowat alle medische domeinen. ZNA Middelheim biedt de meest diverse technische en bloedonderzoeken. Je kan er onze specialisten raadplegen in de polikliniek, opgenomen worden in het ziekenhuis of een behandeling krijgen in het dagziekenhuis."

During the past decade, Ziekenhuis Netwerk Antwerpen Middelheim conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 6 clinical trials were completed, i.e. on average, 17.1% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 2 clinical trials were completed. i.e. 13.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ziekenhuis Netwerk Antwerpen Middelheim" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 12 trials, followed by "Universitaire Ziekenhuizen KU Leuven" with 5 trials sponsored, "Amgen" with 3 trials sponsored, "Gilead Sciences" with 3 trials sponsored and "ID3 Medical" with 3 trials sponsored. Other sponsors include 35 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ziekenhuis Netwerk Antwerpen Middelheim" #1 collaborator was "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials as a collaborator, "Lymphoma Trials Office" with 3 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "Australasian Leukaemia and Lymphoma Group" with 2 trials as a collaborator and "Belgian Hematological Society" with 2 trials as a collaborator. Other collaborators include 58 different institutions and companies that were collaborators in the rest 62 trials.

According to Clinical.Site data, the most researched conditions in "Ziekenhuis Netwerk Antwerpen Middelheim" are "Lymphoma" (5 trials), "Breast Cancer" (4 trials), "Metastatic Cancer" (4 trials), "Lung Cancer" (3 trials) and "Myelodysplastic Syndromes" (3 trials). Many other conditions were trialed in "Ziekenhuis Netwerk Antwerpen Middelheim" in a lesser frequency.

Most popular intervention types in "Ziekenhuis Netwerk Antwerpen Middelheim" are "Drug" (38 trials), "Procedure" (11 trials), "Biological" (9 trials), "Device" (8 trials) and "Other" (7 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (6 trials), "Placebo" (4 trials), "doxorubicin hydrochloride" (4 trials), "etoposide" (4 trials) and "fluorouracil" (4 trials). Other intervention names were less common.

The vast majority of trials in "Ziekenhuis Netwerk Antwerpen Middelheim" are 58 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Ziekenhuis Netwerk Antwerpen Middelheim". 1 are not yet recruiting, 12 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Ziekenhuis Netwerk Antwerpen Middelheim, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Ziekenhuis Netwerk Antwerpen Middelheim, 0 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 14 trials that are defined as “Not Applicable".